22 results found.

Hepatic Complications, Liver Metastases, or Unspecified Adult Sol Clinical Trial using trametinib; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I Trial of Single Agent Trametinib (GSK1120212) in Advanced Cancer Patients With Hepatic Dysfunction.
trametinib; pharmacological study; laboratory biomarker analysis

Colon Cancer, Rectum Cancer, or Liver Metastases Clinical Trial using Lap+Lus

Odense University Hospital - Recruiting 18 years or older.
- The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum: A Prospective Randomized Trial.
Lap+Lus

Metastatic Colorectal Cancer Clinical Trial using FOLFOXIRI + Cetuximab; FOLFOXIRI

Sun Yat-sen University - Recruiting 18 years to 75 years.
- A Phase II Study to Evaluate the Surgical Conversion Rate in Patients Receiving FOLFOXIRI +/- Cetuximab for Unresectable Wild-Type KRAS/NRAS Colorectal Cancer With Metastases Confined to the Liver.
FOLFOXIRI + Cetuximab; FOLFOXIRI

Liver Metastases, Stage IVA Colon Cancer, Stage IVB Colon Cancer, Clinical Trial using dynamic contrast-enhanced ultrasound imaging

Stanford University - Recruiting 18 years or older.
- Pilot Feasibility Study on 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Patients With Liver Metastases.
dynamic contrast-enhanced ultrasound imaging

Colorectal Neoplasms Clinical Trial using Regorafenib (Stivarga, BAY73-4506); Placebo

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled Phase-III Study of Adjuvant Regorafenib Versus Placebo for Patients With Stage IV Colorectal Cancer After Curative Treatment of Liver Metastases.
Regorafenib (Stivarga, BAY73-4506); Placebo

Neuroendocrine Tumor (NET) Liver Metastases Clinical Trial using Holmium-166 microspheres hepatic radioembolization.

UMC Utrecht - Recruiting N/A or older.
- Adjuvant Hepatic Holmium-166-radioembolization in Patients With Unresectable Liver Metastases of Neuroendocrine Origin, Who Have Been Treated With Lutetium-177-dotatate; a Single Center, Interventional, Non-randomized, Non-comparative, Open Label, Phase II Study.
Holmium-166 microspheres hepatic radioembolization.

Liver Cancer, or Metastatic Cancer Clinical Trial using capecitabine; yttrium Y 90 glass microspheres

Northwestern University - Recruiting 18 years or older.
- Dose Escalating Study of Yttrium 90 Microspheres (TheraSphere) With Capecitabine (Xeloda) for Intrahepatic Cholangiocarcinoma or Metastatic Disease to the Liver.
capecitabine; yttrium Y 90 glass microspheres

Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Bod Clinical Trial using ipilimumab; yttrium Y 90 glass microspheres; laboratory biomarker analysis

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver.
ipilimumab; yttrium Y 90 glass microspheres; laboratory biomarker analysis

Colorectal Cancer, Neoplasm Metastasis Clinical Trial using bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- A Multi-center, Single-arm, Pilot Study of 5-FU Based Doublet Chemotherapy Plus Bevacizumab as Neoadjuvant Therapy for Patients With Previously Untreated Unresectable Liver-only Metastases From Colorectal Cancer.
bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Colorectal Cancer Metastatic, Liver Metastases, or KRAS Wild Type Clinical Trial using FOLFOX6; Bevacizumab; Panitumumab; Surgery

European Organisation for Research and Treatment of Cancer - EORTC - Recruiting 18 years to 75 years.
- Randomized Phase II Trial Evaluating the Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab as Perioperative Treatment in Patients With Resectable Liver Metastases From Wild Type KRAS Colorectal Cancer.
FOLFOX6; Bevacizumab; Panitumumab; Surgery

Colorectal Cancer Clinical Trial using bevacizumab [Avastin]; mFOLFOX6

Hoffmann-La Roche - Recruiting 18 years or older.
- A Multi-center, Open-label Clinical Trial to Evaluate the Objective Response Rate of Bevacizumab in Combination With Modified FOLFOX-6 Followed by One Year of Maintenance With Bevacizumab Alone in Patients With Initially Not or Borderline Resectable Colorectal Liver Metastases (The CLMO-001 Trial).
bevacizumab [Avastin]; mFOLFOX6

Colorectal Cancer Clinical Trial using Cetuximab; Bevacizumab; Irinotecan; Oxaliplatin; 5-FU; Folinic Acid

Technische Universit„t Dresden - Recruiting 18 years or older.
- Open, Randomized, Multicenter Phase II Trial With Cetuximab /5-FU/FA/Irinotecan or Cetuximab/5-FU/FA /Irinotecan/Oxaliplatin in K-ras/B-raf Wild Type Patients or With Irinotecan/Oxaliplatin/5-FU/FA With or Without Bevacizumab in K-ras Mutant Patients as Neoadjuvant Treatment in Patients With Non- Resectable Colorectal Liver Metastases..
Cetuximab; Bevacizumab; Irinotecan; Oxaliplatin; 5-FU; Folinic Acid

Cancer, Metastases, or Liver Neoplasms Clinical Trial using Liver MRI with Gdfos; Liver MRI with EcGd

Sunnybrook Health Sciences Centre - Recruiting 18 years or older.
- Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial.
Liver MRI with Gdfos; Liver MRI with EcGd

Metastatic Breast Cancer, Lung Metastases, or Liver Metastases Clinical Trial using anti-OX40 antibody

Providence Health & Services - Recruiting 18 years or older.
- Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy..
anti-OX40 antibody

Liver Metastases Clinical Trial using Proton; Proton Radiation

Loma Linda University - Recruiting 18 years or older.
- Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases.
Proton; Proton Radiation

Liver Metastases, or Primary Liver Cancers Clinical Trial using administration of rRp450 into the hepatic artery

Massachusetts General Hospital - Recruiting 18 years or older.
- rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors.
administration of rRp450 into the hepatic artery

Solid Tumor, or Liver Metastases Clinical Trial using stereotactic body radiotherapy-photon; Stereotactic body radiotherapy-proton

Massachusetts General Hospital - Recruiting 18 years or older.
- Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases.
stereotactic body radiotherapy-photon; Stereotactic body radiotherapy-proton

Secondary Malignant Neoplasm of Liver, or Colorectal Neoplasms Clinical Trial using Open liver resection; Laparoscopic liver resection

Oslo University Hospital - Recruiting 18 years or older.
- Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases.
Open liver resection; Laparoscopic liver resection

Colorectal and Ovarian Cancer Patients With Liver Metastasis Clinical Trial using EMD525797

Merck KGaA - Recruiting 18 years or older.
- A Phase I, Open-label, Dose-escalation Study to Investigate the Safety, Tolerability, PD and PK of EMD 525797 Using DCE-MRI as a PK Measure of Response in Colorectal and Ovarian Cancer Patients With Liver Metastases After Failure of Standard Therapy.
EMD525797

Rectal Cancer, or Liver Metastases Clinical Trial using Capecitabine, Oxaliplatin; Radiotherapy

Asan Medical Center - Recruiting 20 years to 75 years.
- Randomized Phase II Trial of Preoperative Chemoradiation With or Without Induction Chemotherapy In Patients With Locally Advanced Or Borderlinely Resectable Rectal Cancer With Resectable Synchronous Liver Metastases.
Capecitabine, Oxaliplatin; Radiotherapy

Metastatic Colorectal Cancer Clinical Trial using Perfusion CT scan

University of Oxford - Recruiting 18 years or older.
- Perfusion Computed Tomography Pilot Study in the NCRN FOXFIRE Clinical Trial to Determine Blood Flow to Liver Metastases.
Perfusion CT scan

Colorectal Cancer, Liver Neoplasms, Hepatocellular Carcinoma, Gal Clinical Trial using interventionally implanted hepatic arterial port catheter

Charite University, Berlin, Germany - Recruiting 18 years or older.
- Open One-Arm Therapy Optimizing Trial on Regional Chemotherapy of the Liver Through an Interventionally Implanted A.Hepatica Port System in Patients With Liver Metastases or Primary Liver Neoplasms..
interventionally implanted hepatic arterial port catheter